Statistics about Health, Pharma & Medtech in United States
Statistics
- Reviva Pharmaceuticals Holdings, Inc. liabilities 2019-2023
- Travere Therapeutics, Inc. total assets 2019-2023
- Denali Therapeutics net cash 2019-2023
- Denali Therapeutics total equity 2019-2023
- Reviva Pharmaceuticals Holdings, Inc. operating profit 2019-2023
- Denali Therapeutics liabilities 2019-2023
- Recursion Pharmaceuticals operating profit 2019-2023
- Denali Therapeutics total assets 2019-2023
- Athenex, Inc. net cash 2016-2020
- Oragenics Inc gross profit 2013-2017
- Avalon Globocare Corp. net income 2019-2023
- Rhythm Pharmaceuticals total assets 2019-2023
- Aura Biosciences total equity 2019-2023
- Aura Biosciences total assets 2020-2023
- Aura Biosciences net cash 2020-2023
- Aura Biosciences liabilities 2020-2023
- Oragenics Inc operating profit 2019-2023
- Reviva Pharmaceuticals Holdings, Inc. total equity 2019-2023
- Recursion Pharmaceuticals total equity 2019-2023
- Aura Biosciences net income 2020-2023
- Aura Biosciences operating profit 2020-2023
- Astria Therapeutics, Inc. total assets 2019-2023
- Astria Therapeutics, Inc. total equity 2019-2023
- Opko Health gross profit 2009-2012
- Atara Biotherapeutics revenue 2022-2023
- Recursion Pharmaceuticals total assets 2020-2023
- Astria Therapeutics, Inc. net cash 2019-2023
- Astria Therapeutics, Inc. liabilities 2019-2023
- Astria Therapeutics, Inc. operating profit 2019-2023
- Atara Biotherapeutics total equity 2019-2023
- Astria Therapeutics, Inc. net income 2019-2023
- Reviva Pharmaceuticals Holdings, Inc. total assets 2019-2023
- Atara Biotherapeutics liabilities 2019-2023
- Atara Biotherapeutics net cash 2019-2023
- Atara Biotherapeutics operating profit 2019-2023
- Atara Biotherapeutics net income 2019-2023
- Atara Biotherapeutics total assets 2019-2023
- Axsome Therapeutics total equity 2019-2023
- Axsome Therapeutics operating profit 2019-2023
- Oragenics Inc revenue 2013-2023
- Novaccess Global liabilities 2019-2023
- Oruka Therapeutics, Inc. net cash 2019-2023
- Oruka Therapeutics, Inc. total assets 2019-2023
- Oruka Therapeutics, Inc. operating profit 2019-2023
- Regulus Therapeutics revenue 2017-2021
- Regen Biopharma revenue 2019-2023
- Novaccess Global total assets 2019-2023
- Novaccess Global net cash 2019-2023
- Novaccess Global total equity 2019-2023
- Replimune Group total equity 2019-2023
- Novaccess Global revenue 2018-2023
- Novaccess Global operating profit 2019-2023
- Novaccess Global gross profit 2018-2023
- Oruka Therapeutics, Inc. total equity 2019-2023
- Novaccess Global net income 2009-2013
- Renovacor, Inc. total equity 2018-2021
- Rebus Holdings total equity 2018-2022
- Rani Therapeutics Holdings total equity 2020-2023
- Replimune Group total assets 2019-2023
- Renovacor, Inc. total assets 2019-2021
- Otonomy total equity 2017-2021
- Rebus Holdings total assets 2018-2022
- Oramed Pharmaceuticals total equity 2019-2023
- Axcella Health total equity 2018-2022
- Axcella Health net cash 2018-2022
- Oruka Therapeutics, Inc. liabilities 2019-2023
- Relay Therapeutics revenue 2020-2023
- Axcella Health total assets 2018-2022
- Dermtech, Inc. net cash 2019-2023
- Dermtech, Inc. operating profit 2019-2023
- Onconetix, Inc. net income 2022-2023
- Bio-Path Holdings revenue 2014-2018
- Bio-Path Holdings operating profit 2019-2023
- Bio-Path Holdings net income 2022-2023
- Dermtech, Inc. total assets 2019-2023
- Dermtech, Inc. revenue 2019-2023
- Veracyte total equity 2019-2023
- Dermtech, Inc. liabilities 2019-2023
- Ayala Pharmaceuticals total assets 2019-2022
- Onconetix, Inc. operating profit 2021-2023
- Dermtech, Inc. net income 2019-2023
- Ocean Biomedical, Inc. liabilities 2021-2022
- Veru total equity 2019-2023
- Volitionrx total equity 2019-2023
- Vanda Pharmaceuticals total equity 2019-2023
- Dermtech, Inc. gross profit 2019-2023
- Vaxart revenue 2019-2023
- Ayala Pharmaceuticals operating profit 2019-2022
- Ayala Pharmaceuticals net cash 2019-2022
- Ayala Pharmaceuticals gross profit 2019-2022
- Ayala Pharmaceuticals revenue 2019-2022
- Ayala Pharmaceuticals net income 2019-2021
- Ocean Biomedical, Inc. total assets 2021-2022
- Ocean Biomedical, Inc. total equity 2021-2022
- Rani Therapeutics Holdings total assets 2020-2023
- Opko Health total equity 2019-2023
- Axsome Therapeutics liabilities 2019-2023
- Otonomy net cash 2017-2021
- Rani Therapeutics Holdings liabilities 2020-2023
- Atreca, Inc. liabilities 2018-2022